Andreas Axen
GE Healthcare
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andreas Axen.
Journal of Chromatography A | 2009
Ann Marie Hardin; Chithkala Harinarayan; Gunnar Malmquist; Andreas Axen; Robert van Reis
Dynamic binding capacity (DBC) of a monoclonal antibody on agarose based strong cation exchange resins is determined as a function of resin ligand density, apparent pore size of the base matrix, and protein charge. The maximum DBC is found to be unaffected by resin ligand density, apparent pore size, or protein charge within the tested range. The critical conductivity (conductivity at maximum DBC) is seen to vary with ligand density. It is hypothesized that the maximum DBC is determined by the effective size of the proteins and the proximity to which they can approach one another. Once a certain minimum resin ligand density is supplied, additional ligand is not beneficial in terms of resin capacity. Additional ligand can provide flexibility in designing ion exchange resins for a particular application as the critical conductivity could be matched to the feedstock conductivity and it may also affect the selectivity.
Journal of Chromatography A | 2009
David S. Hart; Chithkala Harinarayan; Gunnar Malmquist; Andreas Axen; Mandakini Sharma; Robert van Reis
Increased recombinant protein expression yields and a large installed base of manufacturing facilities designed for smaller bulk sizes has led to the need for high capacity chromatographic resins. This work explores the impact of three pore sizes (with dextran distribution coefficients of 0.4, 0.53, and 0.64), dextran surface extender concentration (11-20mg/mL), and ligand density (77-138 micromol H+/mL resin) of cation exchange resins on the dynamic binding capacity of a therapeutic antibody. An intermediate optimal pore size was identified from three pore sizes examined. Increasing ligand density was shown to increase the critical ionic strength, while increasing dextran content increased dynamic binding capacity mainly at the optimal pore size and lower conductivities. Dynamic binding capacity as high as 200mg/mL was obtained at the optimum pore size and dextran content.
Archive | 2006
Andreas Axen; Anders Hagvall; Anders Larsson; Nicolas Thevenin
Archive | 2003
Andreas Axen; Jean-Luc Maloisel; John Clachan; Helena Lindgren; Anne Catharina Bergh
Archive | 2010
Cecilia Annerén; Andreas Axen; Åsa Bjurling; Lundström Christine Sund; Alstine James Van; Gunnar Fröman
Archive | 2008
Asa Rudstedt; Andreas Axen; Nils Norrman; Anders Larsson
Archive | 2006
Andreas Axen; Gunnar Glad; Henrik Ihre; Anders Larsson; Nils Norrman
Archive | 2007
Inger I. A. Andersson; Andreas Axen; Peder Bergvall; John Clachan; Camilla Estmer-Nilsson; Lena M. Sandberg
Archive | 2006
Andreas Axen; Gunnar Glad; Henrik Ihre; Anders Larsson; Nils Norrman
Archive | 2007
Andreas Axen; Anders Larsson; Nils Norrman